Boehringer Ingelheim has laid the foundation stone for its European Veterinary Research Center in Hanover.
Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of 15 mg/ml for use in pigs.
Boehringer Ingelheim’s Metacam® (active ingredient: Meloxicam) 5mg/ml solution for injection obtained EU wide marketing authorization for its use as an analgesic to relieve post operative pain associated with castration in piglets.
Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces Drs. Keith Bretey, Erin Johnson, Jeff Okones and Brian Payne, all professional service veterinarians for the company’s swine division, completed the Executive Veterinary Program (EVP) for Swine Health and Production program at the University of Illinois.
Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the 2013 recipients of its annual Advancement in PRRS Research Awards. This year, BIVI awarded $75,000 to support three separate studies by independent swine researchers and practitioners in their investigations of novel ways to diagnose, control and eliminate this costly swine disease.
Read and download the posters.
It should always be the goal to create an ideal thermal environment for both the high performing sow and her offspring.
Get the latest news on Swine Health Subscribe to our newsletter